{"title":"增强面部皮肤嫩肤：4mhz单极射频减少面部皱纹的临床评价","authors":"Chuanqi Xie, Hongyang Ma, Sohaib Shujaat, Yu Han","doi":"10.1155/dth/6411705","DOIUrl":null,"url":null,"abstract":"<p><b>Objective:</b> To investigate the effectiveness and safety of 4 MHz monopolar radiofrequency in enhancing facial wrinkles.</p><p><b>Methods:</b> A prospective experimental study was conducted involving 62 facial skin aging patients treated at the Medical Cosmetic Dermatology Department of Shangqiu First People’s Hospital between June 2022 and December 2022. These patients received treatment using a 4 MHz monopolar radiofrequency device. Patients with facial skin aging underwent Fitzpatrick facial wrinkle grading and VISIA image acquisition at baseline, immediately after treatment, and 30- and 90-days post-treatment; adverse events were also recorded.</p><p><b>Results:</b> After administering noninvasive radiofrequency treatment to 62 patients with facial skin aging, 41 demonstrated significant improvement 90 days post-treatment, with 17 classified as effective and 4 as ineffective. The overall clinical effectiveness rate was 93.55%. Ninety days following radiofrequency therapy, Fitzpatrick facial wrinkle grading was repeated for the patients with facial skin aging. Fifteen patients were classified as Grade I, 28 as Grade II, and 19 as Grade III, revealing significant differences before and after treatment (<i>χ</i><sup>2</sup> = 16.1, <i>p</i> = 0.013). Adverse reactions were limited to mild erythema and edema, and no complications such as postinflammatory hyperpigmentation, epidermal burns, fat atrophy, or scarring, were observed in any patients.</p><p><b>Conclusion:</b> The application of monopolar radiofrequency for facial rejuvenation is safe, effective, and associated with minimal adverse reactions.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2025 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/dth/6411705","citationCount":"0","resultStr":"{\"title\":\"Enhancing Facial Skin Rejuvenation: A Clinical Evaluation of 4 MHz Monopolar Radiofrequency in Reducing Facial Wrinkles\",\"authors\":\"Chuanqi Xie, Hongyang Ma, Sohaib Shujaat, Yu Han\",\"doi\":\"10.1155/dth/6411705\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Objective:</b> To investigate the effectiveness and safety of 4 MHz monopolar radiofrequency in enhancing facial wrinkles.</p><p><b>Methods:</b> A prospective experimental study was conducted involving 62 facial skin aging patients treated at the Medical Cosmetic Dermatology Department of Shangqiu First People’s Hospital between June 2022 and December 2022. These patients received treatment using a 4 MHz monopolar radiofrequency device. Patients with facial skin aging underwent Fitzpatrick facial wrinkle grading and VISIA image acquisition at baseline, immediately after treatment, and 30- and 90-days post-treatment; adverse events were also recorded.</p><p><b>Results:</b> After administering noninvasive radiofrequency treatment to 62 patients with facial skin aging, 41 demonstrated significant improvement 90 days post-treatment, with 17 classified as effective and 4 as ineffective. The overall clinical effectiveness rate was 93.55%. Ninety days following radiofrequency therapy, Fitzpatrick facial wrinkle grading was repeated for the patients with facial skin aging. Fifteen patients were classified as Grade I, 28 as Grade II, and 19 as Grade III, revealing significant differences before and after treatment (<i>χ</i><sup>2</sup> = 16.1, <i>p</i> = 0.013). Adverse reactions were limited to mild erythema and edema, and no complications such as postinflammatory hyperpigmentation, epidermal burns, fat atrophy, or scarring, were observed in any patients.</p><p><b>Conclusion:</b> The application of monopolar radiofrequency for facial rejuvenation is safe, effective, and associated with minimal adverse reactions.</p>\",\"PeriodicalId\":11045,\"journal\":{\"name\":\"Dermatologic Therapy\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/dth/6411705\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatologic Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/dth/6411705\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologic Therapy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/dth/6411705","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的：探讨4mhz单极射频增强面部皱纹的有效性和安全性。方法：对2022年6月至2022年12月在商丘市第一人民医院内科美容皮肤科就诊的62例面部皮肤老化患者进行前瞻性实验研究。这些患者接受了4兆赫单极射频设备的治疗。面部皮肤老化患者在基线、治疗后立即、治疗后30天和90天分别进行Fitzpatrick面部皱纹分级和VISIA图像采集；不良事件也有记录。结果：对62例面部皮肤老化患者进行无创射频治疗，治疗90 d后明显改善41例，有效17例，无效4例。总临床有效率为93.55%。射频治疗90天后，对面部皮肤老化患者重复Fitzpatrick面部皱纹分级。1级15例，2级28例，3级19例，治疗前后差异有统计学意义（χ2 = 16.1, p = 0.013）。不良反应仅限于轻度红斑和水肿，未见任何患者出现炎症后色素沉着、表皮烧伤、脂肪萎缩或瘢痕形成等并发症。结论：应用单极射频治疗面部年轻化安全、有效，不良反应小。
Enhancing Facial Skin Rejuvenation: A Clinical Evaluation of 4 MHz Monopolar Radiofrequency in Reducing Facial Wrinkles
Objective: To investigate the effectiveness and safety of 4 MHz monopolar radiofrequency in enhancing facial wrinkles.
Methods: A prospective experimental study was conducted involving 62 facial skin aging patients treated at the Medical Cosmetic Dermatology Department of Shangqiu First People’s Hospital between June 2022 and December 2022. These patients received treatment using a 4 MHz monopolar radiofrequency device. Patients with facial skin aging underwent Fitzpatrick facial wrinkle grading and VISIA image acquisition at baseline, immediately after treatment, and 30- and 90-days post-treatment; adverse events were also recorded.
Results: After administering noninvasive radiofrequency treatment to 62 patients with facial skin aging, 41 demonstrated significant improvement 90 days post-treatment, with 17 classified as effective and 4 as ineffective. The overall clinical effectiveness rate was 93.55%. Ninety days following radiofrequency therapy, Fitzpatrick facial wrinkle grading was repeated for the patients with facial skin aging. Fifteen patients were classified as Grade I, 28 as Grade II, and 19 as Grade III, revealing significant differences before and after treatment (χ2 = 16.1, p = 0.013). Adverse reactions were limited to mild erythema and edema, and no complications such as postinflammatory hyperpigmentation, epidermal burns, fat atrophy, or scarring, were observed in any patients.
Conclusion: The application of monopolar radiofrequency for facial rejuvenation is safe, effective, and associated with minimal adverse reactions.
期刊介绍：
Dermatologic Therapy has been created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities. Each issue of the journal consists of a series of scholarly review articles written by leaders in dermatology in which they describe, in very specific terms, how they treat particular cutaneous diseases and how they use specific therapeutic agents. The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations. Because of the specific and practical nature of this publication, Dermatologic Therapy not only serves as a readily available resource for the day-to-day treatment of patients, but also as an evolving therapeutic textbook for the treatment of dermatologic diseases.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
